Innovation1 Biotech Inc.
IVBT
$0.0002
-$0.0006-75.00%
OTC PK
| 11/30/2023 | 08/31/2023 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | -12.78% | -12.29% | |||
| Depreciation & Amortization | 0.00% | 0.00% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -12.81% | -12.23% | |||
| Operating Income | 12.81% | 12.23% | |||
| Income Before Tax | 94.27% | -1,390.26% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 94.27% | -1,390.26% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 94.27% | -1,390.26% | |||
| EBIT | 12.81% | 12.23% | |||
| EBITDA | 12.78% | 12.29% | |||
| EPS Basic | 89.94% | -793.36% | |||
| Normalized Basic EPS | 81.36% | -348.91% | |||
| EPS Diluted | 89.94% | -793.36% | |||
| Normalized Diluted EPS | 81.36% | -348.91% | |||
| Average Basic Shares Outstanding | 3.17% | 0.74% | |||
| Average Diluted Shares Outstanding | 3.17% | 0.74% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||